|
|
|
|
Delayed enrollment can cost oncology trials up to $250K per patient. Explore the barriers keeping patients out and practical ways to reach more of them faster.
|
|
|
|
|
When Madeline Naylor, Citeline’s Chief Clinical Officer, lost her father to esophageal cancer, it fueled her passion for matching patients with lifesaving clinical trials. See how she brings her experience as a principal investigator and her personal passion to her day-to-day job.
|
|
|
|
|
Numerous barriers prevent eligible patients from reaching the trials that could help them. This webinar covers practical strategies to make recruitment faster, more precise, and more predictable.
|
|
|
|
|
Some patients shun breast cancer trial participation due to overwhelm, unclear communication, and lack of trust. Discover strategies to address these obstacles while centering the patient in the process.
|
|
|
|
|
Recruitment bottlenecks threatened the progress of a Phase II trial for patients with extensive-stage and previously treated small cell lung cancer. To overcome these challenges, the sponsor deployed Citeline PatientMatch, which featured tailored alerts and algorithmic precision for a scalable, cost-effective approach to solving complex recruitment challenges.
|
|
|
|
|
|
|
